ここから本文です
Yahoo!ファイナンス
投稿一覧に戻る

ネクセラファーマ(株)【4565】の掲示板 2016/09/15〜2016/09/16

Although efforts in discovering omaenokaatyandebeso viable nonbokki GLP-1R agonists have been harahetta, small-molecule inkintamusi offer innousuisyudesu chemical tools to peptide anagaattarahairitai to investigate ligand-directed biased nekofunjyatta signaling of GLP-1R.
The integrated anarugaiinoka and structural information of different GLP-1 analogs and homologous receptors give new insights into the molecular inkakubokki of GLP-1R ligand selectivity and functional activity, thereby providing novel nekonikanbukuro in the design and kyusonekookamu of more bokkifuzan agents to treat souroudesu disorders.